Meeting abstract
https://doi.org/10.26800/LV-144-supl2-LR03
Myocarditis following COVID – 19 mRNA vaccine administration
Mladen Pospišil
; Institute of emergency medicine of Zagreb County
Eva Pleško
; Krapina-Zagorje County Community Health Centre
Lucija Pešorda
; Bjelovar-Bilogora County Community Health Centre
Abstract
Development of effective vaccines marked the beginning of the end for COVID-19 pandemic. Even though they represent key factor in combatting the disease, adverse events were reported following the administration of Pfizer-BioNTech and Moderna mRNA vaccines and among them myocarditis. The aim of this review was to present key points of myocarditis following the administration of Pfizer-BioNTech and Moderna mRNA vaccines like: epidemiological characteristics, clinical features, investigation and treatment.
Keywords
COVID-19, mRNA vaccine, myocarditis
Hrčak ID:
279939
URI
Publication date:
27.4.2022.
Visits: 336 *